Activin and Inhibin

(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha ( ERRa ) binding group. PROTAC ERRα Degrader-1 is an

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(S)-Baxdrostat is the S-enantiomer of Baxdrostat. Baxdrostat is an aldosterone synthase inhibitor.Form:Solid.

(S)-Baxdrostat is the S-enantiomer of Baxdrostat. Baxdrostat is an aldosterone synthase inhibitor.Form:Solid.

(S)-Baxdrostat is the S-enantiomer of Baxdrostat. Baxdrostat is an aldosterone synthase inhibitor.Form:Solid.

(S)-Baxdrostat is the S-enantiomer of Baxdrostat. Baxdrostat is an aldosterone synthase inhibitor.

(S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)In VitroThe β-receptor blocking activity of (S)-Carvedilol is about 100

(S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)In VitroThe β-receptor blocking activity of (S)-Carvedilol is about 100